NexoBrid (Anacaulase-bcdb)
- Drug Name: NexoBrid
- API: Anacaulase-bcdb
- Dosage Forms and Strengths: NexoBrid, topical gel: 8.8%
- Manufactured by: Vericel Corporation
- The safety and effectiveness of NexoBrid have not been established for the treatment of:
- Chemical or electrical burns.
- Burns on the face, perineum, or genitalia.
- Burns on the feet of patients with diabetes mellitus or on the feet of patients with occlusive vascular disease.
- Circumferential burns.
- Burns in patients with significant cardiopulmonary disease, including inhalation injury.
- For topical use only.
- NexoBrid may be applied in up to two applications of 4 hours each.
- A first application may be applied to an area of up to 15% body surface area (BSA).
- A second application may be applied 24 hours later. The total treated area for both applications must not exceed 20% BSA.
- Prepare NexoBrid at the patient’s bedside within 15 minutes of the intended application.
- Apply NexoBrid to a clean, moist wound bed free of burned epidermis layer and blisters, and cover with an occlusive film dressing for 4 hours.
- Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylaxis, have been reported with postmarketing use of anacaulase-bcdb. If a hypersensitivity reaction occurs, remove NexoBrid (if applicable) and initiate appropriate therapy.
- Pain: Manage pain as appropriate for an extensive dressing change of burn wounds. Ensure adequate pain control measures are in place at least 15 minutes before NexoBrid -related procedures.
- Proteolytic Injury to Non-Target Tissues: NexoBrid obird is not recommended for the treatment of burn wounds where medical devices or vital structures could become exposed during eschar removal. Protect any open wounds with skin protectant ointments or ointment gauze to prevent possible exposure to NexoBrid .
- Coagulopathy: Avoid the use of NexoBrid in patients with uncontrolled disorders of coagulation. Use with caution in patients on anticoagulant therapy or other drugs affecting coagulation, and in patients with low platelet counts and increased risk of bleeding from other causes. Monitor patients for possible signs of coagulation abnormalities and signs of bleeding.
If you are considering the import of NexoBrid (Anacaulase-bcdb) to India, please be aware that Elahere can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:
Required Documentation for Import:
- A valid prescription from a qualified medical practitioner.
- Diagnostic reports of the patient.
- Government-issued identification proof for the patient, as recognized by the Government of India.
Order Confirmation Process:
The order for NexoBrid (Anacaulase-bcdb) will be confirmed upon the receipt of the following documents:
- A valid prescription from a qualified doctor.
- An import permit, if applicable.
NexoBrid (Anacaulase-bcdb) is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.
NexoBrid can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.
IPN (Indian Pharma Network) is dedicated to facilitating the supply of Elahere (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.
Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.
Indian Pharma Network is proficient in sourcing NexoBrid (Anacaulase-bcdb) from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.